BSE Live
Oct 31, 16:01Prev. Close
381.75
Open Price
388.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:40Prev. Close
384.30
Open Price
387.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
388.35 (30)
| Key Financial Ratios of Kilitch Drugs (India) (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 19.37 | 11.03 | 10.09 | 6.76 | 3.98 | |
| Diluted EPS (Rs.) | 19.37 | 11.03 | 10.09 | 6.76 | 3.98 | |
| Cash EPS (Rs.) | 20.45 | 11.70 | 10.94 | 7.37 | 4.71 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 157.28 | 138.61 | 125.74 | 114.25 | 105.16 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 157.28 | 138.61 | 125.74 | 114.25 | 105.16 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 112.91 | 81.83 | 75.59 | 67.49 | 45.19 | |
| PBDIT/Share (Rs.) | 27.70 | 16.48 | 13.97 | 9.98 | 6.07 | |
| PBIT/Share (Rs.) | 26.62 | 15.71 | 13.11 | 9.36 | 5.33 | |
| PBT/Share (Rs.) | 25.30 | 14.52 | 12.48 | 8.94 | 4.85 | |
| Net Profit/Share (Rs.) | 19.37 | 10.93 | 10.09 | 6.76 | 3.97 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 24.53 | 20.14 | 18.48 | 14.79 | 13.43 | |
| PBIT Margin (%) | 23.57 | 19.19 | 17.34 | 13.87 | 11.80 | |
| PBT Margin (%) | 22.40 | 17.74 | 16.51 | 13.24 | 10.72 | |
| Net Profit Margin (%) | 17.15 | 13.35 | 13.34 | 10.01 | 8.79 | |
| Return on Networth / Equity (%) | 12.31 | 7.88 | 8.02 | 5.91 | 3.77 | |
| Return on Capital Employed (%) | 15.23 | 11.32 | 10.42 | 8.18 | 5.05 | |
| Return on Assets (%) | 8.69 | 6.11 | 6.22 | 4.53 | 3.14 | |
| Total Debt/Equity (X) | 0.19 | 0.14 | 0.11 | 0.11 | 0.09 | |
| Asset Turnover Ratio (%) | 0.56 | 0.49 | 0.49 | 0.49 | 0.38 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.10 | 2.20 | 2.03 | 1.81 | 2.21 | |
| Quick Ratio (X) | 1.91 | 2.14 | 2.00 | 1.72 | 2.10 | |
| Inventory Turnover Ratio (X) | 18.82 | 43.63 | 16.54 | 14.04 | 8.31 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 622.93 | 639.66 | 221.35 | 279.20 | 134.52 | |
| EV/Net Operating Revenue (X) | 3.43 | 4.86 | 1.88 | 2.66 | 1.92 | |
| EV/EBITDA (X) | 13.98 | 24.13 | 10.17 | 17.95 | 14.30 | |
| MarketCap/Net Operating Revenue (X) | 3.20 | 4.76 | 1.85 | 2.48 | 1.79 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 2.30 | 2.81 | 1.11 | 1.47 | 0.77 | |
| Price/Net Operating Revenue | 3.20 | 4.76 | 1.85 | 2.48 | 1.79 | |
| Earnings Yield | 0.05 | 0.03 | 0.07 | 0.04 | 0.05 |
20.05.2025
Kilitch Drugs Consolidated March 2025 Net Sales at Rs 61.23 crore, up 36.61% Y-o-Y
20.05.2025
Kilitch Drugs Standalone March 2025 Net Sales at Rs 56.30 crore, up 43.87% Y-o-Y
28.02.2025
Kilitch Drugs Consolidated December 2024 Net Sales at Rs 56.17 crore, up 76.65% Y-o-Y
17.02.2025
Kilitch Drugs Standalone December 2024 Net Sales at Rs 46.51 crore, up 56.27% Y-o-Y